news & articles
Announcement - Hydrix is pleased to announce it has been accepted as a member of the Ventri Clinical network, Australia’s Gateway for Cardiovascular Medtech Innovation.
LUDO is a tailored plug-and-play pump controller platform for MCS developers, built on proven safety critical architecture.
Joshan Joy explains the importance of how to stay approved: Why compliance with changing global post-market requirements matters.
Angel Medical Systems has completed its first commercial implantation in the USA of the Guardian device.
AngelMed receives USA FDA approval for the Guardian® device. Hydrix to submit local regulatory approval applications.
Vickie brings more than 25 years’ relevant health technology industry expertise and a deep commercial capability to successfully bring new interventional cardiac devices to market.
David Hawks, Hydrix’s new Senior VP of Business Development and Strategy, shares his insights and observations on the status of MedTech funding and innovation, more than a year on from COVID-19
Hydrix Medical is proud to be sponsoring Singapore LIVE 2021, a conference dedicated to cardiovascular intervention in the Asia-Pacific region
First in human clinical trial of the Phyzhon PHYRARI FFR-Wire System will involve approximately 50 patients, commencing in March Quarter 2021
Hydrix is proud to have collaborated with ANSTO on the development of a breakthrough Gamma radiation detection system, the CORIS360™
Hydrix Medical to distribute Phyzhon Health’s disposable fibre optic pressure sensor guidewire used for interventional cardiology procedures
Join Michelle Knight, Regulatory & Clinical Manager at Hydrix, as part of the discussion on “The role of digital health in clinical trials” Register now!
A small token of appreciation for our relentless ‘Quaranteam’. To all Hydrix team members, we thank you.
Hydrix joins Gyder Surgical and FB Rice to explore the insights manufacturing can provide to tech start-ups from innovation to commercialisation
Hydrix receives two prestigious Good Design Awards for its outstanding design and engineering work on the Memphasys Felix, a novel IVF technology
Australian Stock Exchange (ASX) announcement on implants of AngelMed Guardian devices undertaken in Singapore recently
The Hydrix team is looking forward to collaborating with Venstra Medical to help them develop their ground-breaking technology
This webinar provides medical device innovators with an increased understanding of the manufacturing regulatory process.
Michelle Knight, Clinical and Regulatory Manager at Hydrix outlines opportunities to be found through expedited regulatory pathways
The Director Business Development - Consumer and Industrial at Hydrix has been elected to the Board of the Australian Innovation Research Group (AIRG)
Hydrix Medical has been established to support our marketing and distribution of cardiovascular products and technologies in the Asia-Pacific market.
Industry experts from Hydrix and FB Rice reveal and discuss strategies to help you navigate a more certain regulatory and IP landscape.
In the mining industry, the need to develop more robust and reliable control systems is becoming apparent.
There is always an ongoing need in the mining industry to drive process improvement, reduce costs, and improve yields. Our team has been applying innovation process to assist in bringing these goals to reality.
The implanted AngelMed Guardian device alerts patients to seek medical attention even if they have no apparent symptoms
Introducing Yael Rosenberg. Software Group Manager, and advocate for empowering teams and individuals to achieve great outcomes.
As the first in a series of brief articles introducing the Hydrix team, Regulatory Affairs Consultant Tajanka Mladenovska discusses her role, her passion for education and the broader world of medical device development.
A range of market forces are driving innovation in the Australian mining industry. Ahead of the GMG Forum in Perth, Hydrix’s Brad Phillips provides an introduction into how you can ensure more consistent outcomes from your innovation activities.
Hydrix has secured a significant development project with US-based medical device company, Angel Medical Systems Inc. (AngelMed) to integrate new and updated technologies into their Guardian System®.
Three years of development came down to a single moment in time. As the team gathered at mission headquarters, thoughts turned to all that could go wrong. But the launch was seamless.
Cardiac assist devices including Ventricular Assist Devices (VADs) together with Total Artificial Hearts (TAHs) are becoming an increasingly common alternative for many people throughout the world.
The Melbourne Space Program (MSP), a charity focussing on developing university students to become Australian space industry leaders, and Hydrix, a leading product design and engineering consulting company, have announced a MOU to collaborate on the development of space-related projects.